Cells in various benign and malignant conditions of the human prostate express different antigenic phenotypes

International Urology and Nephrology

Volumn 30, Issue 6, 1998, Pages 731-744

  Turhan, O I ^a   Aydin, N E ^a   Sariyuce O ^a   Ozkan S ^a  

^a INONU UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN A; PROSTATE SPECIFIC ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; BENIGN TUMOR; CELL DIFFERENTIATION; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT NEOPLASTIC DISEASE; PROSTATE CANCER; PROSTATE DISEASE; PROSTATECTOMY; TRANSURETHRAL RESECTION;

EID: 0032460573     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02564862     Document Type: Article

References (43)

1. Wojno, K. J., Epstein, J. I.: The utility of basal cell specific anti-cytokeratin antibody (34BE12) in the diagnosis of prostate cancer. A review of 228 cases. Am. J. Surg. Pathol., 19 (3), 251 (1995).
2. Brawer, M. K., Peehl, D. M., Stamey, T. A., Bostwick, D. G.: Keratin immunoreactivity in the benign and neoplastic human prostate. Cancer Res., 45, 3663 (1985).
3. Epstein, J. I.: The prostate and seminal vesicles. In: Stephen S. Sternberg (ed.): Diagnostic Surgical Pathology. Raven Press Ltd., New York 1994, pp. 1807-1853.
4. Shah I. A., Schlageter, M. O., Stinnett, P., Lechago, J.: Cytokeratin immunohistochemistry as a diagnostic tool for distinguishing malignant from benign epithelial lesions of the prostate. Mod. Pathol., 4 (2), 220 (1991).
5. Epstein, J. I.: Differential diagnoses in pathology: Urologic disorders. Igaku-Shoin, New York 1992, pp. 132-133.
6. Bonkoff, H., Stein, U., Remberger, K.: Endocrine-paracrine cell types in the prostate and prostatic adenocarcinoma are postmitotic cells. Hum. Pathol., 26 (2), 167 (1995).
7. Bonkoff, H., Remberger, K.: Widespread distribution of nuclear androgen receptors in the basal cell layer of the normal and hyperplastic human prostate. Virchows Arch [A] Pathol. Anat. Histopathol., 422, 35 (1993).
8. Bostwick, D. G., Amin, M. B.: Prostate and seminal vesicles. In: Damyanow. I., Linder, J. (eds): Anderson's Pathology. Mosby-Year Book, St. Louis, Missouri 1996, pp. 2197-2230.
9. Cotran, S., Kumar, V., Robbins, S. L.: Male genital system. In: W. B. Saunders Staff (eds): Robbins Pathologic Basis of Disease. W. B. Saunders, Philadelphia 1989, pp. 1099-1126.
10. Lin, J. I., Cohen, E. L., Villacim, A. B., Garcia, M. B., Tseng, C. H.: Basal-cell adenoma of prostate. Urology, 11, 409 (1978).
11. Ayala, A. G., Srigley, J. R., Ro, J. Y., Abdul-Karim, F. W., Johnson, D. E.: Clear cell cribriform hyperplasia of the prostate: Report of 10 cases. Am. J. Surg. Pathol., 10, 665 (1986).
12. Frauenhoffer, E., Ro, J. Y., El-Naggar, A. K., Ordonez, N. G., Ayala, A. G.: Clear cell cribriform hyperplasia of the prostate: Immonohistochemical and flow cytometric study. Am. J. Clin Pathol., 95, 446 (1991).
13. Mostofi, F. K., Sesterhen, I. A., Davis, C. J. Jr.: Prostatic carcinoma: Problems in the interpretation of prostatic biopsies. Hum. Pathol., 23, 223 (1992).
14. Özoran, Y.: Use of immunohistochemical markers and histochemical methods as adjunct in the diagnosis of the prostatic carcinoma. Turkish Journal of Neoplasia, 2 (3), 107 (1994).
15. Bostwick, D. G., Srigley, J. R.: Premalignant lesions. In: Pathology of the Prostate. Churchill Livingstone, New York 1990, pp. 37-59.
16. Weinstein, M. H., Greenspan, D. L., Epstein, J. I.: Diagnoses rendered on prostate needle biopsy in community hospitals. Mod. Pathol., 8, 85 A (1995).
17. Bostwick, D. G., Brawer, M, K.: Prostatic intraepithelial neoplasia and early invasion in prostate cancer. 59, 788 (1987).
18. Gardner, W. A. Jr., Culberson, D. E.: Atrophy and proliferation in the young adult prostate. J. Urol., 137, 53 (1987).
19. Hedrick, L., Epstein, J. I.: Use of keratin 903 as an adjunct in the diagnosis of prostatic carcinoma. Am. J. Surg. Pathol., 13, 389 (1989).
20. Epstein, J. I.: Prostate Biopsy Interpretation. Prostatic intraepithelial neoplasia. Lippincott-Raven, Philadelphia-New York 1995, pp. 37-61.
21. Ellis, D. W., Leffers, S., Davies, J. S., Ng, A. B. P.: Multiple immunoperoxidase markers in benign hyperplasia and adenocarcinoma of the prostate. Am. J Clin. Pathol., 81, 279 (1984).
22. Bonkoff, H., Stein, U., Remberger, K.: Multidirectional differentiation in the normal, hyperplastic and neoplastic human prostate: Simultaneous demonstration of cell-specific epithelial markers. Hum. Pathol., 25 (1), 42 (1994).
23. Malpica, A., Ro, J. Y., Troncosos, P., Ordonez, N. G., Amin, M. B., Ayala, A. G.: Nephrogenic adenoma of the prostatic urethra involving the prostatic gland: A clinicopathologic and immunohistochemical study of eight cases. Hum. Pathol., 25, 390 (1994).
24. Young, R. H.: Nephrogenic adenomas of the urethra involving the prostate gland: A report of two cases of a lesion that may be confused with prostatic adenocarcinoma. Mod. Pathol., 617 (1992).
25. Devaraj, L. T., Bostwick, D. G.: Atypical basal cell hyperplasia of the prostate. Immunophenotypic profile and proposed classification of basal cell proliferations. Am J Surg. Pathol., 17, 645 (1993).
26. Epstein, J. I., Armas, O. A.: Atypical basal cell hyperplasia of the prostate: A benign lesion not to be mistaken for malignancy. Am. J. Surg. Pathol., 16, 1205 (1992).
27. Bostwick, D. G.: Prostate specific antigen. Current role in diagnostic pathology of prostate cancer. Am J Clin. Pathol., 102 (Suppl. 1), S31 (1994).
28. Bostwick, D. G., Dousa, M. K., Crawford, B. G., Wollan, P. C.: Neuroendocrine differentiation in prostatic intraepithelial neoplasia and adenocarcinoma. Am. J. Surg. Pathol., 18 (12), 1240 (1994).
29. Cohen, R. J., Glezerson, G., Haffejee, Z.: Neuroendocrine cells - A new prognostic parameter in prostate cancer. Br. J. Urol., 68, 258 (1991).
30. Van de Voorde W., Von Poppel, H., Haustermans, K., Baert, L., Lauweyns, J.: Mucin secreting adenocarcinoma of the prostate with neuroendocrine differentiation. Case report. Am. J. Surg. Pathol., 18 (2), 200 (1994).
31. Fetissof, F., Bertrand, G., Guilloteay, D., Dubois, M. P., Lanson, Y., Arbeille, B.: Calcitonin immunoreactive cells in prostate gland and cloacal derived tissues. Virchows Arch. (A), 409, 523 (1986).
32. Adlakha, H., Bostwick, D.: Paneth cell-like change in prostatic adenocarcinoma represents neuroendocrine differentiation: Report of 30 cases. Hum. Pathol , 25 (2), 135 (1994).
33. Azzopardi, J. G., Evans, D. J.: Argentaffin cells in prostatic carcinoma: Differentiation from lipofuscin and melanin in prostatic epithelium. J. Pathol., 104, 247 (1971).
34. Dayal, Y.: Endocrine cells of the gut and their neoplasms. In: Norris, H. T. (ed.): Pathology of the Colon, Small Intestine and Anus. Churchill Livingstone, New York 1983, pp. 267-300.
35. Epstein, J. I., Partin, A. W., Weltri, R. W.: Neuroendocrine differentiation in prostate cancer: Enhanced prediction of progression following radical prostatectomy. Mod. Pathol. 8, 75 A (1995).
36. di Sant'Agnese, P. A., Jensen, K. D.: Endocrine-paracrine cells of the prostate and prostatic urethra. An ultrastructural study. Hum. Pathol., 15, 1034 (1984).
37. di Sant'Agnese, P. A.: Neuroendocrine differentiation in human prostatic carcinoma. Hum. Pathol., 23, 287 (1992).
38. Fetisoff, F., Dubois, M. P., Arbeille Brassart, B.: Endocrine cells of the prostate gland, urothelium, and Brenner tumors. Immunohistological and ultrastructural studies. Virchows Arch [Cell Pathol.], 42, 53 (1983).
39. Ro, J. Y., Tetu, B., Ayala, A. G., Ordonez, N. G.: Small cell carcinoma of the prostate: Immunohistochemical and electronmicroscopic studies in 18 cases. Cancer, 59, 977 (1987).
40. Sappino, A. P., McLhinney, R. A. J., Ellison, M.: A monoclonal antibody detecting neural and neuroendocrine differentiation. J. Histochem. Cytochem., 32, 1041 (1984).
41. Berner, A., Nesland, J. M., Waehre, H., Slide, J., Fossa, S. D.: Hormone resistant prostatic adenocarcinoma: An evaluation of prognostic factors in pre- and post-treatment specimens. Br. J. Cancer, 68, 380 (1993).
42. Van Welden, J. J., Heyns, C. F.: Neuroendocrine cells of as a prognostic indicator in prostate cancer. Br. J. Urol., 751 (1995).
43. Wright, C., Grignon, D., Shum, D., Porter, A.: Neuroendocrine differentiation in prostatic adenocarcinoma is not an independent prognostic indicator. Mod. Pathol., 5, 61A (1992).